<p>根据公司在最近向美国证券交易委员会提交的 13F 文件，Concentric Capital Strategies LP 在第四季度将其在丹纳赫公司（NYSE:DHR - 免费报告）的持股减少了 80.6%。该基金在季度内出售了 5,790 股后，持有该综合企业的 1,392 股股票。Concentric Capital Strategies LP 在丹纳赫的持股在最近一个季度末价值为 320,000 美元。</p>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>其他几家对冲基金最近也对其在该公司的持仓进行了调整。第一夏威夷银行在第四季度将其在丹纳赫的股份增加了 10.9%。第一夏威夷银行现在拥有 5,220 股该综合企业的股票，价值为 1,198,000 美元，此前在上个季度购买了 512 股。哈德逊谷投资顾问公司在第四季度将其在丹纳赫的持股增加了 1.9%。哈德逊谷投资顾问公司现在拥有 47,003 股该综合企业的股票，价值为 10,790,000 美元，此前在该期间购买了 897 股。ORG Partners LLC 在第四季度将其在丹纳赫的持仓增加了 1,212.8%。ORG Partners LLC 现在拥有 2,770 股该综合企业的股票，价值为 636,000 美元，此前在上个季度收购了 2,559 股。财富提升顾问服务公司在第四季度将其在丹纳赫的持股增加了 0.3%。财富提升顾问服务公司现在拥有 199,493 股该综合企业的股票，价值为 45,794,000 美元，此前在该期间收购了 591 股。最后，ST Germain D J Co. Inc.在第四季度将其在丹纳赫的持仓提高了 13.9%。ST Germain D J Co. Inc.现在拥有 3,558 股该综合企业的股票，价值为 817,000 美元，此前在上个季度收购了 433 股。79.05% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>丹纳赫股票上涨 0.9%</h2>
<p>丹纳赫股票在周五开盘价为 194.86 美元。该公司的市值为 1394.5 亿美元，市盈率为 36.90，市盈增长比率为 2.66，贝塔系数为 0.80。该公司的债务与股本比率为 0.31，速动比率为 1.05，流动比率为 1.40。该企业的 50 日移动平均线为 198.72 美元，200 日移动平均线为 219.95 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 281.70 美元。</p>
<ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近在 4 月 22 日发布了季度财报。该综合企业报告每股收益（EPS）为 1.88 美元，超出分析师一致预期的 1.62 美元，超出幅度为 0.26 美元。丹纳赫的净利润率为 16.33%，股本回报率为 10.82%。该公司在本季度的收入为 57.4 亿美元，而一致预期为 55.8 亿美元。整体来看，分析师预测丹纳赫公司在当前年度的每股收益将达到 7.63 美元。</p>
<h2>丹纳赫宣布分红</h2>
<p>该企业最近还宣布了一项季度分红，将于 7 月 25 日（星期五）支付。6 月 27 日（星期五）登记在册的股东将获得每股 0.32 美元的分红。这代表着每年 1.28 美元的分红和 0.66% 的收益率。丹纳赫的分红支付比率目前为 24.85%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
<p>几位股票研究分析师最近对 DHR 股票进行了评估。雷蒙德·詹姆斯在 2 月 3 日的研究报告中重申了对丹纳赫股票的 “市场表现” 评级。巴克莱在 4 月 22 日的研究报告中将丹纳赫股票的目标价从 205.00 美元上调至 215.00 美元，并给予该股票 “增持” 评级。杰富瑞金融集团在 4 月 22 日的研究报告中将丹纳赫股票的目标价从 260.00 美元下调至 230.00 美元，并对该股票设定了 “买入” 评级。瑞银集团在 4 月 23 日的研究报告中将丹纳赫股票的目标价从 275.00 美元下调至 240.00 美元，并对该公司设定了 “买入” 评级。最后，花旗集团在 4 月 7 日的研究报告中重申了对丹纳赫股票的 “买入” 评级。五位股票研究分析师对该股票给予了持有评级，十六位分析师给予了该公司买入评级。根据 MarketBeat.com 的数据，丹纳赫目前的共识评级为 “适度买入”，平均目标价为 264.40 美元。</p>
<p><strong>获取我们最新的丹纳赫股票报告</strong></p>
<h2>内部人士下注</h2>
<p>在相关消息中，执行副总裁 Christopher Paul Riley 在 4 月 30 日的交易中出售了 15,805 股丹纳赫股票。这些股票以 198.00 美元的平均价格出售，总交易额为 3,129,390.00 美元。交易完成后，该执行副总裁现在持有 15,179 股公司股票，价值约为 3,005,442 美元。此次交易使其持仓减少了 51.01%。该交易已在向证券交易委员会的备案中披露，可以通过此链接访问。公司内部人士持有公司股票的 11.10%。</p>
<h2>丹纳赫简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>相关文章</h2>
<ul>
<li>我们更看好的五只股票超过丹纳赫</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>IBM 的人工智能攻势：评估 IBM 重获增长的路径</li>
<li>什么是热门股票？热门股票解析</li>
<li>罗克韦尔自动化：美国生产回流的顺风</li>
<li>使用 MarketBeat 股息税计算器</li>
<li>能源转移是被低估还是价值陷阱？</li>
</ul>
<p><strong>想看看其他对丹纳赫持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

第一夏威夷

丹纳赫

<p>Concentric Capital Strategies LP 大幅减少了在丹纳赫公司（NYSE:DHR）的持股比例，下降了 80.6%，在第四季度出售了 5,790 股，剩余 1,392 股，价值 320,000 美元。其他对冲基金也调整了他们的持仓，第一夏威夷银行将其持股增加了 10.9%。丹纳赫最近报告了强劲的季度收益，超出预期，并宣布每股派发季度股息 0.32 美元。分析师对丹纳赫保持乐观，给予 “适度买入” 的共识评级，平均目标价为 264.40 美元</p>

<p>Concentric Capital Strategies LP reduced its holdings in Danaher Co. (NYSE:DHR - Free Report) by 80.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,392 shares of the conglomerate's stock after selling 5,790 shares during the quarter. Concentric Capital Strategies LP's holdings in Danaher were worth $320,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>根据公司在最近向美国证券交易委员会提交的 13F 文件，Concentric Capital Strategies LP 在第四季度将其在丹纳赫公司（NYSE:DHR - 免费报告）的持股减少了 80.6%。该基金在季度内出售了 5,790 股后，持有该综合企业的 1,392 股股票。Concentric Capital Strategies LP 在丹纳赫的持股在最近一个季度末价值为 320,000 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>Several other hedge funds have also recently made changes to their positions in the business. First Hawaiian Bank boosted its stake in shares of Danaher by 10.9% during the 4th quarter. First Hawaiian Bank now owns 5,220 shares of the conglomerate's stock valued at $1,198,000 after purchasing an additional 512 shares in the last quarter. Hudson Valley Investment Advisors Inc. ADV lifted its holdings in Danaher by 1.9% in the fourth quarter. Hudson Valley Investment Advisors Inc. ADV now owns 47,003 shares of the conglomerate's stock worth $10,790,000 after buying an additional 897 shares during the period. ORG Partners LLC boosted its position in Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after acquiring an additional 2,559 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Danaher by 0.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 199,493 shares of the conglomerate's stock worth $45,794,000 after acquiring an additional 591 shares during the period. Finally, ST Germain D J Co. Inc. raised its position in shares of Danaher by 13.9% in the 4th quarter. ST Germain D J Co. Inc. now owns 3,558 shares of the conglomerate's stock worth $817,000 after acquiring an additional 433 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金最近也对其在该公司的持仓进行了调整。第一夏威夷银行在第四季度将其在丹纳赫的股份增加了 10.9%。第一夏威夷银行现在拥有 5,220 股该综合企业的股票，价值为 1,198,000 美元，此前在上个季度购买了 512 股。哈德逊谷投资顾问公司在第四季度将其在丹纳赫的持股增加了 1.9%。哈德逊谷投资顾问公司现在拥有 47,003 股该综合企业的股票，价值为 10,790,000 美元，此前在该期间购买了 897 股。ORG Partners LLC 在第四季度将其在丹纳赫的持仓增加了 1,212.8%。ORG Partners LLC 现在拥有 2,770 股该综合企业的股票，价值为 636,000 美元，此前在上个季度收购了 2,559 股。财富提升顾问服务公司在第四季度将其在丹纳赫的持股增加了 0.3%。财富提升顾问服务公司现在拥有 199,493 股该综合企业的股票，价值为 45,794,000 美元，此前在该期间收购了 591 股。最后，ST Germain D J Co. Inc.在第四季度将其在丹纳赫的持仓提高了 13.9%。ST Germain D J Co. Inc.现在拥有 3,558 股该综合企业的股票，价值为 817,000 美元，此前在上个季度收购了 433 股。79.05% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Danaher Stock Up 0.9 %</h2>
<div class="lb-trans"><h2>丹纳赫股票上涨 0.9%</h2>
</div><p>DHR stock opened at $194.86 on Friday. The company has a market cap of $139.45 billion, a price-to-earnings ratio of 36.90, a P/E/G ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The business's 50-day moving average is $198.72 and its two-hundred day moving average is $219.95. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70.</p>
<div class="lb-trans"><p>丹纳赫股票在周五开盘价为 194.86 美元。该公司的市值为 1394.5 亿美元，市盈率为 36.90，市盈增长比率为 2.66，贝塔系数为 0.80。该公司的债务与股本比率为 0.31，速动比率为 1.05，流动比率为 1.40。该企业的 50 日移动平均线为 198.72 美元，200 日移动平均线为 219.95 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 281.70 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
</div><p>Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. As a group, analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近在 4 月 22 日发布了季度财报。该综合企业报告每股收益（EPS）为 1.88 美元，超出分析师一致预期的 1.62 美元，超出幅度为 0.26 美元。丹纳赫的净利润率为 16.33%，股本回报率为 10.82%。该公司在本季度的收入为 57.4 亿美元，而一致预期为 55.8 亿美元。整体来看，分析师预测丹纳赫公司在当前年度的每股收益将达到 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹纳赫宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.66%. Danaher's dividend payout ratio is presently 24.85%.</p>
<div class="lb-trans"><p>该企业最近还宣布了一项季度分红，将于 7 月 25 日（星期五）支付。6 月 27 日（星期五）登记在册的股东将获得每股 0.32 美元的分红。这代表着每年 1.28 美元的分红和 0.66% 的收益率。丹纳赫的分红支付比率目前为 24.85%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Will Danaher stock hit new highs in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
</div><p>Several equities research analysts recently weighed in on DHR shares. Raymond James reaffirmed a &#34;market perform&#34; rating on shares of Danaher in a research note on Monday, February 3rd. Barclays upped their target price on shares of Danaher from $205.00 to $215.00 and gave the stock an &#34;overweight&#34; rating in a research report on Tuesday, April 22nd. Jefferies Financial Group dropped their price objective on shares of Danaher from $260.00 to $230.00 and set a &#34;buy&#34; rating on the stock in a research note on Tuesday, April 22nd. UBS Group decreased their target price on shares of Danaher from $275.00 to $240.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, April 23rd. Finally, Citigroup reissued a &#34;buy&#34; rating on shares of Danaher in a research report on Monday, April 7th. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $264.40.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 DHR 股票进行了评估。雷蒙德·詹姆斯在 2 月 3 日的研究报告中重申了对丹纳赫股票的 “市场表现” 评级。巴克莱在 4 月 22 日的研究报告中将丹纳赫股票的目标价从 205.00 美元上调至 215.00 美元，并给予该股票 “增持” 评级。杰富瑞金融集团在 4 月 22 日的研究报告中将丹纳赫股票的目标价从 260.00 美元下调至 230.00 美元，并对该股票设定了 “买入” 评级。瑞银集团在 4 月 23 日的研究报告中将丹纳赫股票的目标价从 275.00 美元下调至 240.00 美元，并对该公司设定了 “买入” 评级。最后，花旗集团在 4 月 7 日的研究报告中重申了对丹纳赫股票的 “买入” 评级。五位股票研究分析师对该股票给予了持有评级，十六位分析师给予了该公司买入评级。根据 MarketBeat.com 的数据，丹纳赫目前的共识评级为 “适度买入”，平均目标价为 264.40 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Danaher</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的丹纳赫股票报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Christopher Paul Riley 在 4 月 30 日的交易中出售了 15,805 股丹纳赫股票。这些股票以 198.00 美元的平均价格出售，总交易额为 3,129,390.00 美元。交易完成后，该执行副总裁现在持有 15,179 股公司股票，价值约为 3,005,442 美元。此次交易使其持仓减少了 51.01%。该交易已在向证券交易委员会的备案中披露，可以通过此链接访问。公司内部人士持有公司股票的 11.10%。</p>
</div><h2>Danaher Profile</h2>
<div class="lb-trans"><h2>丹纳赫简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>The 3 Best Fintech Stocks to Buy Now</li>
<li>IBM's AI Offensive: Assessing IBM's Path to Renewed Growth</li>
<li>What Are Trending Stocks? Trending Stocks Explained</li>
<li>Rockwell Automation: Tailwinds From Onshoring U.S. Production</li>
<li>Using the MarketBeat Dividend Tax Calculator</li>
<li>Is Energy Transfer Undervalued or a Value Trap?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过丹纳赫</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>IBM 的人工智能攻势：评估 IBM 重获增长的路径</li>
<li>什么是热门股票？热门股票解析</li>
<li>罗克韦尔自动化：美国生产回流的顺风</li>
<li>使用 MarketBeat 股息税计算器</li>
<li>能源转移是被低估还是价值陷阱？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding DHR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对丹纳赫持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Concentric Capital Strategies LP 出售丹纳赫公司（NYSE:DHR）5,790 股股票